Author: contributing ed.

Author Published on

Brachytherapy- where the seeds go,
Brachytherapy of the prostate: where the seeds go.
April 29, 2015. Many patients with higher-risk localized prostate cancer are treated with external beam radiation or with brachytherapy (seed implants). A clinical trial conducted  by Dr James Miller (right) of Vancouver, Canada has found that patients receiving permanent implant brachytherapy "seeds" plus a boost of radiation  have a better chance of long-term survival than those treated with higher dose-escalated external beam radiotherapy but without the implants.

Men receiving the radioactive "seeds" were more likely to be cancer-free five to nine years later. ...continue reading Brachytherapy combination improves PSA-free survival for patients with higher-risk localized prostate cancer, trial finds

Author Published on

Welcome!  If you're in the PCa boat, we're sorry, but glad that you're reaching out for information from a patient-centered support community.

This year, 2015, according to reliable statistics, some 220,800 men will be diagnosed with prostate cancer and some 27,540 men will die of this disease. If you read medical news, you'll find these and related statistics intoned in virtually every research article. ...continue reading If you’re new here . . .

Author Published on Leave a comment

Posted April 16, 2005. Adding androgen-suppressing drugs to radiation therapy improves chances or long-term survival for men with high-risk prostate cancer

...continue reading Androgen Deprivation Boosts Survival After Radiation for High Risk Prostate Cancer